LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
NCT05663125
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Glioblastoma
Interventions
PROCEDURE:
Laser interstitial thermal therapy
DRUG:
Temozolomide
Sponsor
Beijing Tiantan Hospital